Kalray (ALKAL) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
18 Aug, 2026Executive summary
No significant anomalies were identified in the limited review of the consolidated financial statements for the period ending June 30, 2025, confirming a fair presentation of the group's financial position and results.
Achieved positive EBITDA and free cash flow in H1 2025, marking a significant turnaround driven by strategic refocusing and cost-saving measures.
The group finalized the sale of non-strategic UK assets (Arcapix) for $12.5M upfront, with additional contingent payments possible, and used proceeds to fully repay a €3M revolving credit facility.
Divested the "Data Acceleration Platform"/"Enterprise" business, focusing on core DPU development and co-development/service agreements.
Launched a strategic industrial cooperation with Openchip, opening new commercial opportunities in AI and high-performance computing.
Financial highlights
Revenue for H1 2025 was €7.9M, down from €10.9M year-over-year, mainly due to the business disposal.
Gross margin rose sharply to 87% from 54% year-over-year, reflecting the new business model.
EBITDA turned positive at €253k, compared to (€4.8m) in H1 2024.
Net loss narrowed to €2.1M from €11.1M year-over-year.
Free cash flow was €3.1M as of June 30, 2025, versus (€21.1M) at year-end 2024.
Operating cash flow was negative at -€8.3M, but investing activities generated €12M, mainly from asset sales.
Cash at period end was €2.3M, up from €1.7M at year-end 2024.
Outlook and guidance
Liquidity is secured through September 2026 without new market funding; extending visibility to December 2026 requires drawing the remaining bond facility.
EBITDA expected to be strongly positive for full-year 2025.
Annual revenue projected to decline by 35% due to the business disposal, but to increase fourfold on a like-for-like basis.
Profitability trajectory confirmed, with continued focus on cost control and new business model.
Financing horizon extended to June 30, 2026, supported by new contracts and debt renegotiations.
Latest events from Kalray
- Revenue stable at €24.8M, EBITDA -€8M, and Data Acceleration Platform sold for up to $20M.ALKAL
H2 2024 TU - Revenue quadrupled on a comparable basis, with EBITDA turning strongly positive in 2025.ALKAL
H2 2025 TU - 58% revenue growth and positive EBITDA in H1 2026, with strong outlook for FY2026.ALKAL
H1 2026 TU - First-ever positive EBITDA and free cash flow achieved, with double-digit growth expected in 2026.ALKAL
H2 2025 - Semiconductor growth and strategic refocus drive improved profitability outlook for 2025.ALKAL
H1 2025 TU - Strategic pivot and cost cuts target break-even by end-2025 after a challenging H1 2024.ALKAL
H1 2024 - Strong H2 growth expected as Kalray ramps up a €100M contract and finalizes Pliops deal.ALKAL
H1 2024 TU - Net loss widened to €23.3M in FY2024 as Kalray divested a major business unit and refocused strategy.ALKAL
H2 2024 - Kalray sells Ngenea unit to DataCore, pivots to semiconductors, and seeks liquidity extension.ALKAL
Trading Update